BACKGROUND: Antibody-cytokine fusion proteins consist of cytokines fused to an antibody to improve antibody-targeted cancer immunotherapy. These molecules have the capacity to enhance the tumoricidal activity of the antibodies and/or activate a secondary antitumor immune response. OBJECTIVE: To review the strategies used to develop antibody-cytokine fusion proteins and their in vitro and in vivo properties, including preclinical and clinical studies focusing on IL-2, IL-12 and GM-CSF. METHODS: Articles were found by searching databases such as PubMed and Clinical Trials of the US National Institutes of Health. RESULTS/ CONCLUSION: Multiple antibody-cytokine fusion proteins have demonstrated significant antitumor activity as direct therapeutics or as adjuvants of cancer vaccines in preclinical studies, paving the way for their clinical evaluation.
BACKGROUND: Antibody-cytokine fusion proteins consist of cytokines fused to an antibody to improve antibody-targeted cancer immunotherapy. These molecules have the capacity to enhance the tumoricidal activity of the antibodies and/or activate a secondary antitumor immune response. OBJECTIVE: To review the strategies used to develop antibody-cytokine fusion proteins and their in vitro and in vivo properties, including preclinical and clinical studies focusing on IL-2, IL-12 and GM-CSF. METHODS: Articles were found by searching databases such as PubMed and Clinical Trials of the US National Institutes of Health. RESULTS/ CONCLUSION: Multiple antibody-cytokine fusion proteins have demonstrated significant antitumor activity as direct therapeutics or as adjuvants of cancer vaccines in preclinical studies, paving the way for their clinical evaluation.
Authors: J P Leonard; M L Sherman; G L Fisher; L J Buchanan; G Larsen; M B Atkins; J A Sosman; J P Dutcher; N J Vogelzang; J L Ryan Journal: Blood Date: 1997-10-01 Impact factor: 22.113
Authors: M Imboden; K R Murphy; A L Rakhmilevich; Z C Neal; R Xiang; R A Reisfeld; S D Gillies; P M Sondel Journal: Cancer Res Date: 2001-02-15 Impact factor: 12.701
Authors: Stephen D Gillies; Yan Lan; Steven Williams; Frank Carr; Stephen Forman; Andrew Raubitschek; Kin-Ming Lo Journal: Blood Date: 2005-02-03 Impact factor: 22.113
Authors: Rosendo Luria-Pérez; Pierre V Candelaria; Tracy R Daniels-Wells; José A Rodríguez; Gustavo Helguera; Manuel L Penichet Journal: Cytokine Date: 2019-05-20 Impact factor: 3.861
Authors: Kirstin A Zettlitz; Felix B Salazar; Reiko E Yamada; K Ryan Trinh; Alex Vasuthasawat; John M Timmerman; Sherie L Morrison; Anna M Wu Journal: Mol Cancer Ther Date: 2022-04-01 Impact factor: 6.009
Authors: Daila S Gridley; James M Slater; Xian Luo-Owen; Asma Rizvi; Stephen K Chapes; Louis S Stodieck; Virginia L Ferguson; Michael J Pecaut Journal: J Appl Physiol (1985) Date: 2008-11-06
Authors: Hui Ding; Gustavo Helguera; José A Rodríguez; Janet Markman; Rosendo Luria-Pérez; Pallavi Gangalum; Jose Portilla-Arias; Satoshi Inoue; Tracy R Daniels-Wells; Keith Black; Eggehard Holler; Manuel L Penichet; Julia Y Ljubimova Journal: J Control Release Date: 2013-06-12 Impact factor: 9.776
Authors: Oluwaseyi T Shofolawe-Bakare; Larry D Stokes; Mehjabeen Hossain; Adam E Smith; Thomas A Werfel Journal: Biomater Sci Date: 2020-09-02 Impact factor: 6.843
Authors: E Jensen-Jarolim; H J Bax; R Bianchini; S Crescioli; T R Daniels-Wells; D Dombrowicz; E Fiebiger; H J Gould; S Irshad; J Janda; D H Josephs; F Levi-Schaffer; L O'Mahony; G Pellizzari; M L Penichet; F Redegeld; F Roth-Walter; J Singer; E Untersmayr; L Vangelista; S N Karagiannis Journal: Allergy Date: 2017-10-05 Impact factor: 13.146
Authors: Erica N Bozeman; Rangaiah Shashidharamurthy; Simon A Paulos; Ravi Palaniappan; Martin D'Souza; Periasamy Selvaraj Journal: Front Biosci (Landmark Ed) Date: 2010-01-01